Achieve Life Sciences
$4.64
24H
Market Cap
Volume
Supply
Price Chart
About Achieve Life Sciences - ACHV
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The company focuses on addressing the global smoking health epidemic through effective and accessible cessation solutions.
What are Achieve Life Sciences's core values and mission statement?
Achieve Life Sciences, Inc. is dedicated to the development and commercialization of solutions for smoking cessation and nicotine addiction, with a core mission to improve people’s lives by developing novel treatments that address addiction and related health issues. Their values emphasize a commitment to scientific rigor, integrity, and innovation to serve the healthcare community and patients.
Who founded Achieve Life Sciences and when?
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company that evolved from the merger between OncoGenex Pharmaceuticals, Inc. and Achieve Pharma in 2017, with the latter contributing the product candidate cytisine. The individuals directly responsible for founding the original entities and the exact date of the foundational activities leading to Achieve Life Sciences in its current form are not specified in widely available public records.
Who leads Achieve Life Sciences?
The CEO of Achieve Life Sciences, Inc. is Richard Stewart.
Where is Achieve Life Sciences located, and what is its base country?
Achieve Life Sciences, Inc. is a biopharmaceutical company based in the United States.
On which exchanges is Achieve Life Sciences traded?
Achieve Life Sciences, Inc. is traded on the NASDAQ stock exchange under the ticker symbol ACHV.
Historical data
Achieve Life Sciences (ACHV) Price Live Data
The live price of Achieve Life Sciences (ACHV) is $4.64, with a trading volume of 283,339 in the last 24 hours. Wrapstocks updates the ACHV price in real-time. Achieve Life Sciences is down -7.22% in the last 24 hours. The company has a live market cap of $159,305,856.00 and a supply of 34,341,300 ACHV stocks.
Achieve Life Sciences (ACHV) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 6 hours and 35 minutes.